TrialLeukemia2025

Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial.

Ajibade Ashaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.